IMMUCELL CORP DE
For the period ended Dec 31, 2023. Filed Apr 1, 2024.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2023 · Filed Apr 1, 2024
ICCC$10.26+0.4%Stored close · as of Nov 10, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Balance Sheets as of December 31, 2023 and 2022
BALANCE SHEETS
| As of December 31, | ||
|---|---|---|
| 2023 | 2022 | |
| ASSETS | ||
| CURRENT ASSETS: | ||
| Cash and cash equivalents | $978,741 | $5,791,562 |
| Trade accounts receivable | 2,185,383 | 1,758,600 |
| Inventory | 7,811,841 | 6,038,539 |
| Prepaid expenses and other current assets | 493,885 | 406,055 |
| Total current assets | 11,469,850 | 13,994,756 |
| Property, plant and equipment, net | 27,575,683 | 28,441,726 |
| Operating lease right-of-use asset | 4,571,149 | 2,194,670 |
| Goodwill | 95,557 | 95,557 |
| Intangible assets, net | 38,208 | 57,312 |
| Other assets | 57,655 | 76,628 |
| TOTAL ASSETS | $43,808,102 | $44,860,649 |
| LIABILITIES AND STOCKHOLDERS’ EQUITY | ||
| CURRENT LIABILITIES: | ||
| Current portion of debt obligations | $1,428,807 | $1,039,447 |
| Current portion of operating lease liability | 644,276 | 31,764 |
| Accounts payable and accrued expenses | 2,124,337 | 2,000,862 |
| Total current liabilities | 4,197,420 | 3,072,073 |
| LONG-TERM LIABILITIES: | ||
| Debt obligations, net of current portion | 10,540,496 | 9,191,109 |
| Operating lease liability, net of current portion | 4,077,109 | 2,217,418 |
| Total long-term liabilities | 14,617,605 | 11,408,527 |
| TOTAL LIABILITIES | 18,815,025 | 14,480,600 |
| CONTINGENT LIABILITIES AND COMMITMENTS (See Note 11) | ||
| STOCKHOLDERS’ EQUITY: | ||
| Common stock, $0.10 par value per share, 15,000,000 shares authorized and 7,814,165 shares issued as of both December 31, 2023 and 2022 and 7,750,864 and 7,746,864 shares outstanding as of December 31, 2023 and 2022, respectively | 781,417 | 781,417 |
| Additional paid-in capital | 36,357,239 | 35,978,364 |
| Accumulated deficit | (12,007,097) | (6,232,499) |
| Treasury stock, at cost, 63,301 and 67,301 shares as of December 31, 2023 and 2022, respectively | (138,482) | (147,233) |
| Total stockholders’ equity | 24,993,077 | 30,380,049 |
| TOTAL LIABILITIES AND STOCKHOLDERS’ EQUITY | $43,808,102 | $44,860,649 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.